Update on the metabolic effects of oral contraceptives

Journal of Obstetrics and Gynaecology

Volumn 6, Issue S2, 1986, Pages

  Skouby, S O ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMADINONE; DESOGESTREL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GESTODENE; GLUCOSE; INSULIN; MEDROXYPROGESTERONE; MEGESTROL; MESTRANOL; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PROSTACYCLIN;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DRUG MIXTURE; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPOPROTEINEMIA; LIPID METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; PROTEIN METABOLISM; SHORT SURVEY; THROMBOEMBOLISM;

BIOLOGY; CARDIOVASCULAR EFFECTS; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE METHODS--PHARMACODYNAMICS; CONTRACEPTIVE METHODS--SIDE EFFECTS; DISEASES; ENDOCRINE SYSTEM; FAMILY PLANNING; HORMONES--SIDE EFFECTS; LIPID METABOLIC EFFECTS; LIPIDS; METABOLIC EFFECTS; ORAL CONTRACEPTIVES--PHARMACODYNAMICS; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY; REPRODUCTIVE CONTROL AGENTS;

BIOLOGY; CARDIOVASCULAR SYSTEM; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; DISEASE; ENDOCRINE SYSTEM; FAMILY PLANNING; HORMONES; LIPIDS; METABOLISM; PHYSIOLOGY; REPRODUCTIVE CONTROL AGENTS;

EID: 0022590319     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.3109/01443618609081723     Document Type: Article

References (23)

1. Effects of oral contraceptive on blood coagulation. A review
2. Oral contraceptives and thromboembolic disease: effects of lowering the oestrogen content
3. Serum high-density lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins
4. Glucose clamp technique. A method for quantifying insulin secretion and resistance
5. Changes in insulin receptors during oral contraception
6. Variability of pharmacokinetic parameters for contraceptive steroids
7. Oral contraceptives and cardiovascular disease
8. High density lipoprotein as a protective factor against coronary heart disease: the Framingham study
9. Effects of oral contraceptive agents on carbohydrate metabolism
10. The Royal College of General Practitioners' Oral Contraceptive study: some recent observations
11. Effects of the estrogenicity of levonorgestrel/ethinylestradiol combinations on the lipoprotein status
12. Oral contraceptives and blood coagulation: a critical review
13. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50-and 30-μg oestrogen preparations
14. Clinical pharmacokinetics of oral contraceptive steroids
15. Direct hormonal effects
16. No influence on glucose tolerance of a low estrogen contraceptive in women with a previous gestational diabetes
17. Triphasic oral contraceptives: metabolic effects in normal women and those with previous gestational diabetes
18. The effect of estrogens on carbohydrate metabolism: glucose, insulin and growth hormone studies on one hundred and seventy one women ingesting premarin, mestranol and ethinyl estradiol for six months
19. Carbohydrate and lipid metabolic studies before and after one year of treatment with ethynodiol diacetate in ‘normal’ women
20. Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive
21. Female hormones and vascular disease—an epidemiological overview
22. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use
23. Oral contraceptives and diabetes mellitus